Menu
Gosselies, Belgique

Research Assistant – Immunology – In Vitro Biology (M/F)

  • Type of role R&D, Science & Technology
  • Region Wallonia
  • Activity Biotech

Contact Isabelle Milcent
Email
+32 (0)472 11 13 37

More info on iTeos Therapeutics

iTeos Therapeutics is a publicly-held (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies.

Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics’ goal is to develop a strong clinical pipeline and maintain investments in the discovery research team to improve the lives of cancer patients. For more information, please visit www.iteostherapeutics.com.

iTeos Therapeutics has the ambition to become a world-class actor in the sector. To carry on its growth and reinforce its team, iTeos Therapeutics is offering a full-time permanent position as a (m/f): Research Assistant – Immunology - In Vitro Biology.


Responsibilities:

Within its Preclinical Department, iTeos is looking for a highly motivated and skilled Research Assistant. The successful candidate will help develop breakthrough cancer immunotherapies through laboratory work, supporting the validation of new IO targets but also the discovery of small molecules and biologics for the development of innovative cancer immunotherapies. In this role, the candidate will work independently and as part of a team to generate robust in vitro/ex vivo data packages, helping to guide decision making and timely progression to development and clinical trials. The lab is equipped with state-of-the art technologies to study both in vitro and in vivo experimental models of immunology and cancer.

  • Design, validate and perform experimental in vitro and ex vivo immunoassays on human and mouse samples, using Standard Operating Procedures. Time keeping in the lab is evaluated around 80%.
  • Characterize immune responses ex vivo and in vitro by designing FACS panels, performing flow cytometry and analyzing cytokines/chemokines secretion by ELISA/MSD/Luminex/CBA.
  • Perform in vitro cell culture assays and maintain tumor cell lines.
  • Recognize anomalous and inconsistent results and interpret experimental outcomes.
  • Compile, summarize and analyze data to present them at project team meetings.
  • Propose and implement novel assays or technologies.
  • Collaborate with other project stakeholders and discuss assay results with them.

Profile:

  • Master degree in Life Sciences, Immunology, Pharmacology, Biochemistry, or closely related field.
  • Hands-on experience in setting-up human or mouse immune cell-based assays (isolation, handling of primary immune cells) and multicolor flow cytometry is highly desirable.
  • Additional cell culture and molecular cell biology techniques are important assets (ELISA, qPCR, experience with MSD or Luminex platform, gene expression analysis).
  • Previous experience in the biotech/pharma industry or in a similar academic position is an advantage.
  • Knowledge of Microsoft Office. Knowledge of Prism is a plus.
  • Knowledge of cytometry software such as Diva and FlowJo is a plus.
  • Good command of English (oral and written).
  • Rigorous, detail-oriented, organized, autonomous, committed, and flexible.
  • Team spirit and an inquisitive mindset with strong problem-solving skills are essentials.

Offer:

  • A stimulating scientific position within a high-potential innovative biotech company.
  • The opportunity to work in a science-driven, dynamic, human‐sized, respectful, and professional environment.
  • A challenging scientific and business growth in which you get to bring your knowledge and skills.
  • A permanent contract and an attractive salary package in line with the position responsibilities and your experience.

Your application and related information will remain strictly confidential.

Apply
View all the job vacancies Apply

Professional opportunities

Our latest
job offers

 
An email has been sent to you to validate your subscription to the Newsletter. An error has occurred.